1011.HK · NT PHARMA
Hong Kong · RS rating 41 · As of 2026-10-14
| Price | 0.40 HKD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 41 / 87 / 68 / 11 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 23 / 19 / 14 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +62.6% |
| Market cap (USD) | $93.9M |